Atlas Trials

48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

Clinical trial NCT03845075 · COMPLETED

Trial details

NCT number
NCT03845075
Sponsor
Saniona
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypothalamic Injury-induced Obesity (HIO)
Start date
2019-02-25
Primary completion
2020-10-16
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.